The DEA's 7 OH Ban: A Cautionary Tale of Unintended Consequences The US is on the cusp of a regulatory storm that could have far reaching implications for millions of people living with chronic pain.
On August 5, the Drug Enforcement Administration (DEA) will implement a two year ban on 7 hydroxymitragynine (7 OH), a potent compound found in kratom that activates opioid receptors.
Proponents and detractors of the substance are locked in heated debate.